E-viri
Recenzirano
Odprti dostop
-
Chan, H Y; Ng, C M; Tiu, S C; Chan, Angel O K; Shek, C C
Hong Kong medical journal = Xianggang yi xue za zhi 18, Številka: 6Journal Article
Capecitabine is an orally administered pro-drug of 5-fluorouracil that confers superior disease-free survival and presumably has a more favourable side-effect profile. Here we report on a patient who developed acute necrotising pancreatitis and very high triglyceride levels as well as hand-foot syndrome after receiving capecitabine for colonic cancer. Increased awareness of this potential side-effect and close monitoring of lipid levels may be warranted, especially in patients who have other conditions predisposing them to severe secondary hyperlipidaemia when using this drug.
